Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria.

AIMS Small-conductance calcium-activated potassium (SK) channels are expressed in the heart of various species, including humans. The aim of the present study was to address whether SK channels play a functional role in human atria. METHODS AND RESULTS Quantitative real-time PCR analyses showed higher transcript levels of SK2 and SK3 than that of the SK1 subtype in human atrial tissue. SK2 and SK3 were reduced in chronic atrial fibrillation (AF) compared with sinus rhythm (SR) patients. Immunohistochemistry using confocal microscopy revealed widespread expression of SK2 in atrial myocytes. Two SK channel inhibitors (NS8593 and ICAGEN) were tested in heterologous expression systems revealing ICAGEN as being highly selective for SK channels, while NS8593 showed less selectivity for these channels. In isolated atrial myocytes from SR patients, both inhibitors decreased inwardly rectifying K(+) currents by ∼15% and prolonged action potential duration (APD), but no effect was observed in myocytes from AF patients. In trabeculae muscle strips from right atrial appendages of SR patients, both compounds increased APD and effective refractory period, and depolarized the resting membrane potential, while only NS8593 induced these effects in tissue from AF patients. SK channel inhibition did not alter any electrophysiological parameter in human interventricular septum tissue. CONCLUSIONS SK channels are present in human atria where they participate in repolarization. SK2 and SK3 were down-regulated and had reduced functional importance in chronic AF. As SK current was not found to contribute substantially to the ventricular AP, pharmacological inhibition of SK channels may be a putative atrial-selective target for future antiarrhythmic drug therapy.

[1]  M. Poss,et al.  Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. , 2008, Bioorganic & medicinal chemistry letters.

[2]  Stanley Nattel,et al.  Calcium‐activated potassium current: a novel ion channel candidate in atrial fibrillation , 2009, The Journal of physiology.

[3]  S. Olesen,et al.  Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels , 2000, Pflügers Archiv.

[4]  Huiming Guo,et al.  Decreased expression of small-conductance Ca2+-activated K+ channels SK1 and SK2 in human chronic atrial fibrillation. , 2012, Life sciences.

[5]  Yi Zhang,et al.  Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts* , 2003, Journal of Biological Chemistry.

[6]  A. Goette,et al.  Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. , 2009, Heart rhythm.

[7]  C. January,et al.  Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and I(Kr). , 2006, American journal of physiology. Heart and circulatory physiology.

[8]  John Calvin Reed,et al.  Myocardial cell death in fibrillating and dilated human right atria. , 1999, Journal of the American College of Cardiology.

[9]  D. Jane,et al.  Small conductance calcium-activated potassium channels: From structure to function , 2010, Progress in Neurobiology.

[10]  K. Föhr,et al.  Calculation and control of free divalent cations in solutions used for membrane fusion studies. , 1993, Methods in enzymology.

[11]  Ursula Ravens,et al.  Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. , 2002, Cardiovascular research.

[12]  C. Antzelevitch,et al.  Differential effects of the transient outward K(+) current activator NS5806 in the canine left ventricle. , 2009, Journal of molecular and cellular cardiology.

[13]  U Ravens,et al.  G-Protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents. , 2000, Circulation.

[14]  Jin Jen,et al.  Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation. , 2013, Heart rhythm.

[15]  U. Sørensen,et al.  Cardiac ion channels and mechanisms for protection against atrial fibrillation. , 2012, Reviews of physiology, biochemistry and pharmacology.

[16]  U. Sørensen,et al.  Effects on Atrial Fibrillation in Aged Hypertensive Rats by Ca2+-Activated K+ Channel Inhibition , 2011, Hypertension.

[17]  Ling Lu,et al.  Molecular Coupling of a Ca2+-Activated K+ Channel to L-Type Ca2+ Channels via α-Actinin2 , 2007 .

[18]  B. Nguyen,et al.  Heterogeneous Upregulation of Apamin‐Sensitive Potassium Currents in Failing Human Ventricles , 2013, Journal of the American Heart Association.

[19]  Stanley Nattel,et al.  Regional and tissue specific transcript signatures of ion channel genes in the non‐diseased human heart , 2007, The Journal of physiology.

[20]  K. Lunetta,et al.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation , 2012, Nature Genetics.

[21]  N. Chiamvimonvat,et al.  Cardiac Small Conductance Ca2+-Activated K+ Channel Subunits Form Heteromultimers via the Coiled-Coil Domains in the C Termini of the Channels , 2010, Circulation research.

[22]  Derek J Trezise,et al.  IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform , 2003, Journal of biomolecular screening.

[23]  Thomas Jespersen,et al.  Inhibition of Small-Conductance Ca2+-Activated K+ Channels Terminates and Protects Against Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[24]  Ling Lu,et al.  Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. , 2005, American journal of physiology. Heart and circulatory physiology.

[25]  J. Papp,et al.  Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization? , 2009, Journal of molecular and cellular cardiology.

[26]  J. Nerbonne,et al.  Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.

[27]  D. Dobrev,et al.  The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation , 2005, Circulation.

[28]  Thomas Meitinger,et al.  Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.

[29]  U. Ravens,et al.  Skeletal muscle stem cells propagated as myospheres display electrophysiological properties modulated by culture conditions. , 2011, Journal of molecular and cellular cardiology.

[30]  D. Dobrev,et al.  Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation , 2004, Circulation.

[31]  U. Ravens,et al.  Atrial selectivity of antiarrhythmic drugs , 2013, The Journal of physiology.

[32]  Ling Lu,et al.  α-Actinin2 cytoskeletal protein is required for the functional membrane localization of a Ca2+-activated K+ channel (SK2 channel) , 2009, Proceedings of the National Academy of Sciences.

[33]  Zhao Zhang,et al.  Ablation of a Ca2+‐activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation , 2009, The Journal of physiology.

[34]  Masanori Hirose,et al.  Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. , 2007, Cardiovascular research.

[35]  D. Strøbæk,et al.  Inhibitory Gating Modulation of Small Conductance Ca2+-Activated K+ Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons , 2006, Molecular Pharmacology.

[36]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[37]  M. Lei,et al.  [Increased small conductance calcium-activated potassium channel (SK2 channel) current in atrial myocytes of patients with persistent atrial fibrillation]. , 2011, Zhonghua xin xue guan bing za zhi.

[38]  D. Dobrev,et al.  Role of I Kur in Controlling Action Potential Shape and Contractility in the Human Atrium Influence of Chronic Atrial Fibrillation , 2004 .

[39]  Ursula Ravens,et al.  The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. , 2013, Cardiovascular research.

[40]  S. Nattel,et al.  Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.

[41]  U. Ravens.  Antiarrhythmic therapy in atrial fibrillation. , 2010, Pharmacology & therapeutics.

[42]  U. Sørensen,et al.  The Duration of Pacing-induced Atrial Fibrillation Is Reduced in Vivo by Inhibition of Small Conductance Ca2+-activated K+ Channels , 2011, Journal of cardiovascular pharmacology.

[43]  Changyu Shen,et al.  Apamin-Sensitive Potassium Current Modulates Action Potential Duration Restitution and Arrhythmogenesis of Failing Rabbit Ventricles , 2013, Circulation. Arrhythmia and electrophysiology.

[44]  Ling Lu,et al.  Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. , 2007, Circulation research.

[45]  Robert W. Mills,et al.  Overexpression of KCNN3 results in sudden cardiac death. , 2014, Cardiovascular research.

[46]  A. Waldo,et al.  Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine , 2008 .

[47]  P. Sah,et al.  Small-conductance Ca2+-activated K+ channels: form and function. , 2012, Annual review of physiology.